Case-control study characterizes cytokine levels in HSIL, indicating a unique immune profile.
OBJECTIVES: This study aimed to characterise the local cytokine milieu in the cervicovaginal environment of women with HSIL compared with healthy controls. METHODS: In this case-control study, cervical samples were collected from 84 women aged 20-49 years, including 57 patients with histologically confirmed HSIL and 27 healthy controls. Levels of IL-2, IL-4, IL-6, IL-10, TNF, IFN-γ and IL-17A were quantified in cervicovaginal lavage fluid using a Cytometric Bead Array. Cytokine ratios were calculated to assess the balance between pro-inflammatory and regulatory immune responses. Statistical comparisons between groups were performed using the Mann-Whitney test. RESULTS: Women with HSIL exhibited significantly lower concentrations of TNF (p = 0.030) and IL-2 (p = 0.010) compared with controls. Correspondingly, the TNF/IL-10 (p = 0.018) and TNF/IL-4 (p = 0.032) ratios were markedly decreased, suggesting impaired Th1-mediated immune activation. No significant differences were observed for IL-17A levels or IL-17A/IL-6 ratios, suggesting that Th17-associated soluble mediators may not be the predominant drivers of the observed immunomodulation in this context, although broader Th17 involvement cannot be excluded. CONCLUSIONS: HSIL is characterised by reduced TNF and IL-2 expression and a suppressed TNF/IL-10 and TNF/IL-4 balance, revealing a shift towards an immunoregulatory profile independent of Th17 activity. This cytokine signature suggests an immune milieu favouring lesion persistence and provides a potential framework for developing cytokine-based biomarkers and immunotherapeutic strategies in HPV-associated cervical disease.
No takes yet. Share an insight, caveat, or question.
Pontes et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: